Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix

Neuroendocrine carcinoma of the cervix (NECC) is a highly aggressive and rare gynecological malignancy with a poor prognosis. Despite aggressive local and systemic treatments, there are high rates of locoregional recurrence and distant metastases. Therefore, more potent treatments are required to ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Rongyu, He, Xinlin, Li, Zhengyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712751/
https://www.ncbi.nlm.nih.gov/pubmed/36467090
http://dx.doi.org/10.3389/fphar.2022.1029598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712751/
https://www.ncbi.nlm.nih.gov/pubmed/36467090
http://dx.doi.org/10.3389/fphar.2022.1029598

Ejemplares similares